HLA-DRB1 Antikörper
HLA-DRB1
Reaktivität: Human
WB, IF, IC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN7307126
-
-
Target
Alle HLA-DRB1 Antikörper anzeigen
-
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser HLA-DRB1 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), Immunofluorescence (IF), Immunochromatography (IC)
-
Spezifität
-
Recognizes endogenous levels of HLA-DRB1 protein.
-
Produktmerkmale
-
Rabbit polyclonal antibody to HLA-DRB1
-
Aufreinigung
-
The antibody was purified by immunogen affinity chromatography.
-
Immunogen
-
Recombinant full length protein of human HLA-DRB1
-
Top Product
-
Discover our top product HLA-DRB1 Primärantikörper
-
-
-
Applikationshinweise
-
WB (1:500 - 1:2000), IF/IC (1:50 - 1:100)
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Haltbarkeit
-
12 months
-
-
Target
-
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Andere Bezeichnung
-
HLA-DRB1 (HLA-DRB1 Produkte)
-
Synonyme
-
MGC108235 antikoerper, DRB1 antikoerper, DRw10 antikoerper, HLA-DR1B antikoerper, HLA-DRB antikoerper, SS1 antikoerper, major histocompatibility complex, class II, DR beta 1 antikoerper, hla-drb1 antikoerper, HLA-DRB1 antikoerper
-
Hintergrund
-
HLA class II histocompatibility antigen, DRB1-3 chain, Clone P2-beta-3, MHC class II antigen DRB1*3
-
Gen-ID
-
3123
-
UniProt
-
P01912
-
Pathways
-
T-Zell Rezeptor Signalweg, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Cancer Immune Checkpoints
-